MOLECULAR DOCKING STUDIES ON APIGENIN AS A TARGET WITH MAPK P38 FOR CARDIOVASCULAR DISEASES
Keywords:
Cardiovascular disease, Apigenin, In Silico. MAPK P38.Abstract
Cardiovascular disease (CVD) is a class of diseases that involve the heart or blood vessels (arteries, capillaries and veins). It is the most serious disease on which extensive research is being done all over the world. Structure based drug designing offers a computational approach to identify the potential leads which can be developed into a drug. The In-Silico study of the current work aimed at inhibiting target MAPK P38 protein. This exhibited a minimal energy against the targets hence suggesting the stability of the compound. Five different forms of apigenin were docked against target, stated that all five is efficient to act on the targets by exhibiting promising interactions and good scores. Especially pure form of apigenin shows very efficient score than others. Since it is from a natural source the compound is nontoxic and has reduced side effects.
Downloads
References
McConkey BJ, Sobolev V, Edelman E. (2002) Bioinformatics. 18: 1365–1373
Morris GM, Lim-Wilby M. (2008) Methods Mol Biol. 443:365-82
World Health Organization, 2011
Feigin VL, Lawes CM, Bennett DA, Barker-Collo SL, Parag V. (2009) Lancet Neurol. 8: 355-69
Miean KH, Mohamed S. (2001) J Agric Food Chem 49:3106‑12
Gil‑Saeng J, Seoung‑Hoon L, Seong‑Nyum J, Youn‑Chul K, Eun‑Cheol K. (2009) Int Immunopharmacol 9:1374‑80
Wei H, Tye L, Bresnick E, Birt DF. (1990) Cancer Res 50:499‑502
Braz JC, Bueno OF, Liang Q, Wilkins BJ, Dai YS, Parsons S, Braunwart J, Glascock BJ, Klevitsky R, Kimball TF, Hewett TE, Molkentin JD. (2003) J. Clin. Invest 111:1475–1486
Fukunishi, Y. & Nakamura, H. (2011) Protein Sci. 20: 95-106
Rudnitskaya A, Kirsanov D, Legin A, Beullens K, Lammertyn J, Nicolai BM, Irudayaraj J (2006) Sensor Actuat B-Chem 28: 23-28.
Published
How to Cite
Issue
Section
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
.